Phase I/II trial of hepatic arterial infusion of FMP therapy for advanced hepatocellular carcinoma
Phase 1
- Conditions
- advanced hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000000487
- Lead Sponsor
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1) Prior chemotherapy with 5-fluorouracil, mitoxantrone, and cisplatin for hepatocellular carcinoma 2) Refractory pleural effusion or ascites 3) Allergic reaction to iodine contrast material 4) Severe heart disease 5) Active infection excluding hepatitis B or C viral infection 6) Active concomitant malignancy 7) Severe mental disorder 8) Severe allergic reaction to drug 9) Severe complication 10) Pregnant and lactating females; females of childbearing age unless using effective contraception
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method